Epinephrine (Adrenalin)
Epinephrine is indicated for emergency treatment of type I allergic reactions including anaphylaxis to stinging insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis.
$182.9M in CY2024 Part D spend875K claims · 718K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Epinephrine used for?
Epinephrine is indicated for emergency treatment of type I allergic reactions including anaphylaxis to stinging insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis.
Is there a generic for Epinephrine?
Yes. 10 ANDAs filed at FDA, 6 generic manufacturers currently shipping.
How much does my plan pay for Epinephrine?
Across 329 Part D plans, Epinephrine averages $142.56/unit (NADAC). Lowest available: $1.19/unit. Highest in distribution: $359.49/unit.
Is Epinephrine on the FDA shortage list?
Epinephrine has been discontinued by its manufacturer(s).
8 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.